Study guide
7.3 Nutritional Assessment & Dietary Interventions for Wound Healing
NAWCCB WCC Wound Care Certified Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
About the NAWCCB WCC Exam How to Use This Study Guide
2 Assessment: Skin & Tissue Foundations
1.1 Skin Anatomy, Physiology, and Barrier Function 1.2 Phases of Wound Healing & Cellular Events 1.3 Acute vs. Chronic Wounds & Etiology Classification 1.4 TIME and MEASURE Assessment Frameworks 1.5 Wound Bed Tissue Types & Periwound Assessment 1.6 Pain Assessment: Scales, Wound Pain Types, and Procedural Analgesia 1.7 Psychosocial History, Cognitive Status, and Functional Assessment 1.8 Skin Integrity Across the Lifespan: Neonatal, Pediatric, Adult, and Geriatric
3 Assessment: Diagnostic Tools & Risk Assessment
2.1 Vascular Assessment: ABI, TcPO2, and Arterial/Venous Doppler 2.2 Neuropathy & Monofilament Testing in Diabetic Patients 2.3 Pressure Injury Risk Assessment: Braden Scale Subscales & Scoring 2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI) 2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture 2.6 Laboratory Interpretation in Wound Care: Albumin, Prealbumin, ESR, A1C, CBC, and CMP 2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas
4 Treatment: Dressing Selection & Debridement Modalities
3.1 Principles of Dressing Selection by Exudate & Moisture Balance 3.2 High-Absorbency Dressings: Alginates, Hydrofibers, and Foams 3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels 3.4 Antimicrobial & Biofilm Dressings: Silver, Cadexomer Iodine, and Honey 3.5 Debridement Modalities: Sharp, Enzymatic, Autolytic, Mechanical, & Biosurgical
5 Treatment: Advanced Therapies & Specialized Management
4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions 4.2 Compression Therapy Protocols & ABI Safety Cutoffs 4.3 DFU Off-loading Hierarchy: TCC, RCW, and Therapeutic Footwear 4.4 Support Surfaces, Microclimate Control, & Repositioning Protocols 4.5 Advanced Biologics, Cellular/Tissue Products (CTPs), & HBOT
6 Reevaluation & Wound Healing Trajectory
5.1 Healing Trajectory Benchmarks & Percent Area Reduction (PAR) 5.2 Serial Wound Measurement, Depth Profiling, & Digital Photography 5.3 Treatment Plan Reassessment & Non-Healing Wound Escalation Triggers 5.4 Biofilm Progression & Systemic Infection Re-evaluation 5.5 Palliative Wound Management: Odor, Exudate, and Pain Control 5.6 Validated Healing Instruments: The PUSH Tool, BWAT, and Evaluating Adherence
7 Risk Reduction & Prevention Strategies
6.1 Pressure Injury Prevention: Bundles, Turning Schedules, & Heel Floating 6.2 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD) 6.3 Infection Control, Contact Precautions, & Environmental Hygiene 6.4 Prevention of Skin Tears & Medical Adhesive-Related Skin Injuries (MARSI) 6.5 Diabetic & Venous Ulcer Recurrence Prevention Protocols 6.6 At-Risk Populations: Spinal Cord Injury, Stroke, Critical Care, and Cognitive Impairment
8 Patient & Caregiver Education
7.1 Patient & Caregiver Wound Care Teaching & Self-Management 7.2 Diabetic Foot Self-Inspection & Footwear Education 7.3 Nutritional Assessment & Dietary Interventions for Wound Healing 7.4 Off-loading Compliance & Patient Mobility Education 7.5 Recognizing Complications, Infection Signs, & When to Seek Care 7.6 Educating the Interprofessional Team & Developing Educational Media
9 Administration & Program Management
8.1 Wound Care Documentation Standards & Clinical Records 8.2 Admission Wound Screening & Present on Admission (POA) Documentation 8.3 Interdisciplinary Team Roles & Clinical Care Coordination 8.4 Quality Improvement Metrics & HAPI Tracking Programs 8.5 Wound Care Formulary Management & Resource Utilization
10 Legal, Ethical, & Scope of Practice
9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care 9.2 HIPAA Compliance & Clinical Photography Privacy Standards 9.3 Scope of Practice Across WCC-Eligible Professions (RN, LPN, PT, OT, DPM, MD/DO, PA) 9.4 HAPI Malpractice Liability & Documentation Defense 9.5 Ethical Considerations in Non-Healing Wounds & End-of-Life Skin Care 9.6 Regulatory Compliance, Coding Standards, & Audit Protection
7.3 Nutritional Assessment & Dietary Interventions for Wound Healing
Key Takeaways Explain This Topic AI
Baseline protein intake for wound healing is 1.2 to 1.5 g/kg/day, escalating to 1.5 to 2.0 g/kg/day for extensive exudate, Stage 3–4 pressure injuries, or large open burns.
Energy requirements range from 30 to 35 kcal/kg/day to prevent endogenous lean body mass catabolism and sustain metabolic activity during tissue reconstruction.
Serum biomarkers including prealbumin (<12 mg/dL) and albumin (<3.5 g/dL), alongside unintentional weight loss >5% in 30 days or >10% in 180 days, indicate severe protein-calorie malnutrition.
Supplemental Vitamin C (500–1000 mg/day) is essential for collagen cross-linking, while short-term Zinc supplementation (220 mg zinc sulfate / 50 mg elemental zinc daily for 10–14 days max) supports DNA synthesis.
Daily baseline fluid intake must be maintained at 30 to 35 mL/kg/day unless medical contraindications (e.g., heart failure, end-stage renal disease) dictate strict fluid restriction.
Last updated: August 2026
Nutritional Assessment & Dietary Interventions for Wound Healing
Wound healing is an energy-demanding metabolic process requiring synthesis of new protein, cellular proliferation, extracellular matrix reconstruction, and immunological defense against infection. Protein-calorie malnutrition severely compromises every phase of repair—prolonging inflammation, impairing fibroblast migration, decreasing collagen cross-linking, and weakening wound tensile strength. Systematic nutritional screening, quantitative intake calculations, targeted micronutrient supplementation, and early dietetic interprofessional collaboration are essential clinical responsibilities in wound management.
Pathophysiology of Malnutrition & Lean Body Mass Loss
When caloric or protein intake is insufficient to meet hypermetabolic wound demands, the body enters a catabolic state, breaking down endogenous skeletal muscle (lean body mass [LBM]) to supply amino acids for visceral protein synthesis and glucose obligate tissues.
Physiological Impact of Lean Body Mass Loss
10% LBM Loss: Impaired immune function, increased susceptibility to wound infection.
20% LBM Loss: Delayed wound closure, thinning dermis, loss of skin elasticity.
30% LBM Loss: Stalled healing, spontaneous wound breakdown, development of new pressure injuries.
40% LBM Loss: Fatal outcome (typically secondary to pneumonia or systemic sepsis).
- Macronutrient & Hydration Requirements
- Protein Requirements
Protein is the indispensable building block for tissue repair. It provides amino acids required for collagen synthesis, angiogenesis, fibroblast proliferation, enzyme production, and immune globulin formation.
Baseline Wound Healing: 1.2 to 1.5 g/kg body weight/day (compared to the standard RDA of 0.8 g/kg/day for healthy adults).
Severe Catabolic Wounds / Stage 3–4 Pressure Injuries: 1.5 to 2.0 g/kg body weight/day for patients with heavy exudative losses, extensive burns, or multiple pressure ulcers.
Conditionally Essential Amino Acids:
L-Arginine: Precursor to nitric oxide (promoting vasodilation and tissue perfusion) and hydroxyproline (essential for collagen deposition). Supplemental L-arginine (4.5 to 9.0 g/day) accelerates wound closure.
L-Glutamine: Primary metabolic fuel for proliferating lymphocytes, macrophages, and enterocytes, preserving intestinal barrier integrity during severe stress.
Energy (Caloric) Requirements
Recommended energy intake ranges from 30 to 35 kcal/kg body weight/day (elevated up to 35 to 40 kcal/kg/day for underweight individuals or those undergoing rapid weight loss).
Adequate non-protein calories (carbohydrates and fats) are mandatory to spare dietary protein for tissue building rather than energy oxidation.
Hydration Requirements
Baseline Fluid Intake: 30 to 35 mL/kg body weight/day (or 1.0 to 1.5 mL per kcal consumed).
Additional fluid is required to replace exudate losses from heavily draining wounds, fever, or air-fluidized bed therapy. Dehydration impairs microvascular tissue perfusion and skin turgor.
Clinical Precaution: Adjust fluid goals in patients with congestive heart failure (CHF) or end-stage renal disease (ESRD) under strict nephrology/cardiology guidance.
- Targeted Micronutrient Protocols & Safety Limits
- Vitamin C (Ascorbic Acid)
Function: Required as an essential cofactor for prolyl and lysyl hydroxylase enzymes, which cross-link collagen triple-helix fibers to confer tissue tensile strength. Enhances neutrophil phagocytosis.
Dosage: 500 to 1000 mg/day in divided doses for patients with complex or non-healing wounds.
Zinc
Function: Essential cofactor for over 300 metalloenzymes, including DNA/RNA polymerases, superoxide dismutase, and matrix metalloproteinases (MMPs). Required for cell division and re-epithelialization.
Therapeutic Dosage: 220 mg zinc sulfate daily (supplying 50 mg elemental zinc ).
Strict Safety Limitation: High-dose zinc supplementation must be limited to a maximum of 10 to 14 days . Extended zinc administration competes for intestinal absorption sites with copper, inducing severe copper deficiency anemia, microcytosis, neutropenia, and impaired immunity.
Vitamin A
Function: Stimulates epithelialization, fibrogenesis, and collagen cross-linking. Crucially, Vitamin A reverses the immunosuppressive and anti-inflammatory effects of systemic corticosteroid therapy on wound tissue.
Dosage: Short-term supplemental dose of 10,000 to 25,000 IU/day for 7 to 10 days in patients receiving chronic corticosteroid medications.
Clinical Nutritional Assessment & Biomarkers
Comprehensive nutritional screening must combine validated clinical tools, physical examination, weight history, and laboratory biomarkers.
Screening Tools & Weight History Thresholds
Utilize validated screening tools such as the Malnutrition Universal Self-Tool ( MUST ) or Mini Nutritional Assessment ( MNA ).
Unintentional Weight Loss Cutoffs indicating Malnutrition Risk:
- > 5% weight loss within 30 days
- > 7.5% weight loss within 90 days
- > 10% weight loss within 180 days
Body Mass Index (BMI): A BMI < 18.5 kg/m² indicates severe protein-energy malnutrition.
Laboratory Biomarkers
Prealbumin (Transthyretin): Short half-life of 2 to 3 days , making it the single best visceral protein marker for monitoring rapid acute changes in nutritional intervention efficacy.
- Normal Range: 16 to 35 mg/dL
- Moderate Malnutrition: 10 to 15 mg/dL
- Severe Malnutrition: < 12 mg/dL (or < 10 mg/dL)
Diagnostic Caveat: Prealbumin is a negative acute-phase reactant; levels fall during acute systemic inflammation (elevated C-reactive protein [CRP]) independently of nutritional status.
Serum Albumin: Longer half-life of 18 to 20 days , reflecting long-term baseline protein status. Levels < 3.5 g/dL correlate with increased wound complications and delayed healing.
Interprofessional Escalation: Promptly refer any patient with prealbumin < 12 mg/dL, albumin < 3.5 g/dL, BMI < 18.5 kg/m², or severe unintentional weight loss to a Registered Dietitian (RD/RDN) for specialized enteral/oral supplementation formulation.
Nutritional Parameter Normal / Baseline Value Deficient / Malnutrition Threshold Recommended Clinical Dose for Wounds Key Clinical Precaution
Protein Intake 0.8 g/kg/day < 1.0 g/kg/day 1.2 – 1.5 g/kg/day (1.5 – 2.0 for Stage 3-4) Monitor renal function (BUN/Creatinine)
Energy Intake 20 – 25 kcal/kg/day Weight loss history 30 – 35 kcal/kg/day Ensure adequate non-protein calories
Prealbumin 16 – 35 mg/dL < 12 mg/dL Target > 16 mg/dL via RD plan Levels drop during acute inflammatory CRP surge
Serum Albumin 3.5 – 5.0 g/dL < 3.5 g/dL Target > 3.5 g/dL Long 18-20 day half-life; slow to reflect acute care
Zinc Supplementation Normal dietary Serum zinc low 220 mg zinc sulfate (50 mg elemental) Limit to 10-14 days max to prevent copper anemia
Vitamin C 75 – 90 mg/day Scurvy / delayed repair 500 – 1000 mg/day in divided doses Caution in severe renal failure / oxalosis